 |
Peter Kador, Ph.D. |
NOTE: This profile is part of a series highlighting the 23 researchers who will be honored at an April 6 ceremony for UNMC’s 2009 Scientist Laureate, Distinguished Scientist and New Investigator award recipients.
- Name: Peter Kador, Ph.D.
- Title: Professor of pharmaceutical sciences
- Joined UNMC: 2002
- Hometown: Regensburg, Germany
Describe your research in laymen’s terms.
I conduct translational research on the treatment of diabetic complications and age-related diseases with a focus on cataract, retinopathy, bone loss and neural degenerations.
How does your research contribute to science and/or health care?
These studies provide potential cures for diabetics and patients with age-related disorders. Several are in the process of being tested clinically in both the human and the veterinary market.
Beyond grant funding, how do you measure success?
My reputation and leadership positions among my peers in the ophthalmology and the diabetes research community. I have organized or helped organize more than 30 international workshops/meetings on Aldose Reductase and diabetic complications, cataracts and ocular pharmacology.
List three things few people know about you.
- I was the youngest NIH Staff Fellow (at age 29) to be converted to a permanent Staff Scientist of the National Eye Institute, NIH and I became the equivalent of a full professor at age 39.
- I received the Bundesverdiestkreuz (Cross of Merit) from the German Government for organizing a National German Choral Weekend at the DAR Constitution Hall in Washington and the U.S. Capitol Steps. The event was attended by more than 2,000 participants from across the United States, Canada and Germany.
- I performed at the White House at the invitation of President Clinton.